These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 18686626)

  • 1. Lupus nephritis complicated with malignant hypertension: from renal vascular pathology to clinical relevance.
    Tao JL; Li H; Tang Y; Wen YB; Li XW
    Chin Med Sci J; 2008 Jun; 23(2):81-7. PubMed ID: 18686626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant hypertension in antiphospholipid syndrome without overt lupus nephritis.
    Cacoub P; Wechsler B; Piette JC; Beaufils H; Herreman G; Bletry O; Godeau P
    Clin Exp Rheumatol; 1993; 11(5):479-85. PubMed ID: 8275582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The spectrum of renal thrombotic microangiopathy in lupus nephritis.
    Song D; Wu LH; Wang FM; Yang XW; Zhu D; Chen M; Yu F; Liu G; Zhao MH
    Arthritis Res Ther; 2013 Jan; 15(1):R12. PubMed ID: 23320601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal vascular lesions in lupus nephritis.
    Descombes E; Droz D; Drouet L; Grünfeld JP; Lesavre P
    Medicine (Baltimore); 1997 Sep; 76(5):355-68. PubMed ID: 9352738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The significance of arterial hypertension at the onset of clinical lupus nephritis.
    Naiker IP; Chrystal V; Randeree IG; Seedat YK
    Postgrad Med J; 1997 Apr; 73(858):230-3. PubMed ID: 9156126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics and prognosis of diffuse proliferative lupus nephritis with thrombotic microangiopathy.
    Hu WX; Liu ZZ; Chen HP; Zhang HT; Li LS; Liu ZH
    Lupus; 2010 Dec; 19(14):1591-8. PubMed ID: 20798137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal involvement in systemic lupus erythematosus. A study of 180 patients from a single center.
    Huong DL; Papo T; Beaufils H; Wechsler B; Blétry O; Baumelou A; Godeau P; Piette JC
    Medicine (Baltimore); 1999 May; 78(3):148-66. PubMed ID: 10352647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal vascular lesions as a marker of poor prognosis in patients with lupus nephritis. Gruppo Italiano per lo Studio della Nefrite Lupica (GISNEL).
    Banfi G; Bertani T; Boeri V; Faraggiana T; Mazzucco G; Monga G; Sacchi G
    Am J Kidney Dis; 1991 Aug; 18(2):240-8. PubMed ID: 1867181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of clinical outcomes and renal vascular pathology among patients with lupus.
    Barber C; Herzenberg A; Aghdassi E; Su J; Lou W; Qian G; Yip J; Nasr SH; Thomas D; Scholey JW; Wither J; Urowitz M; Gladman D; Reich H; Fortin PR
    Clin J Am Soc Nephrol; 2012 May; 7(5):757-64. PubMed ID: 22442181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical-pathological features and prognosis of thrombotic thrombocytopenic purpura in patients with lupus nephritis.
    Zheng T; Chunlei L; Zhen W; Ping L; Haitao Z; Weixin H; Caihong Z; Huiping C; Zhihong L; Leishi L
    Am J Med Sci; 2009 Nov; 338(5):343-7. PubMed ID: 19745703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Laboratory and morphologic parameters in patients with lupus nephritis].
    Rasković S; Bogić M; Perić-Popadić A; Stefanović L; Arandjelović S; Jovicić Z; Bolpacić J; Tomić-Spirić V
    Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():38-41. PubMed ID: 12583312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lupus vasculopathy combined with renal infarction: unusual manifestation of lupus nephritis.
    Sugimoto T; Kanasaki K; Morita Y; Yokomaku Y; Narita M; Koyama T; Tanaka Y; Kashiwagi A; Koya D
    Intern Med; 2005 Nov; 44(11):1185-90. PubMed ID: 16357459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interstitial inflammation and long-term renal outcomes in lupus nephritis.
    Alsuwaida AO
    Lupus; 2013 Dec; 22(14):1446-54. PubMed ID: 24097970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin inhibition or blockade for the treatment of patients with quiescent lupus nephritis and persistent proteinuria.
    Tse KC; Li FK; Tang S; Tang CS; Lai KN; Chan TM
    Lupus; 2005; 14(12):947-52. PubMed ID: 16425574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inclusion of renal vascular lesions in the 2003 ISN/RPS system for classifying lupus nephritis improves renal outcome predictions.
    Wu LH; Yu F; Tan Y; Qu Z; Chen MH; Wang SX; Liu G; Zhao MH
    Kidney Int; 2013 Apr; 83(4):715-23. PubMed ID: 23302713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal Interstitial Arteriosclerotic Lesions in Lupus Nephritis Patients: A Cohort Study from China.
    Huang J; Han SS; Qin DD; Wu LH; Song Y; Yu F; Wang SX; Liu G; Zhao MH
    PLoS One; 2015; 10(11):e0141547. PubMed ID: 26544865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-pentraxin 3 auto-antibodies might be protective in lupus nephritis: a large cohort study.
    Yuan M; Tan Y; Pang Y; Li YZ; Song Y; Yu F; Zhao MH
    Ren Fail; 2017 Nov; 39(1):465-473. PubMed ID: 28393653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma ADAMTS-13 activity in proliferative lupus nephritis: a large cohort study from China.
    Tan Y; Luan ZQ; Hao JB; Song D; Yu F; Zhao MH
    Lupus; 2018 Mar; 27(3):389-398. PubMed ID: 28786769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.
    Shen K; Yu Y; Tang Z; Liu Z; Li L
    Chin Med J (Engl); 1997 Jul; 110(7):502-7. PubMed ID: 9594205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential for glomerular C4d as an indicator of thrombotic microangiopathy in lupus nephritis.
    Cohen D; Koopmans M; Kremer Hovinga IC; Berger SP; Roos van Groningen M; Steup-Beekman GM; de Heer E; Bruijn JA; Bajema IM
    Arthritis Rheum; 2008 Aug; 58(8):2460-9. PubMed ID: 18668574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.